Table 4 Aerosol performance of Man+Leu at different dispersion and inspiratory flow rates
From: Aerosol drug delivery to the lungs during nasal high flow therapy: an in vitro study
Dispersion flow rate (L/min) | Inspiratory flow rate (L/min) | Replica deposition (% of loaded dose) | NGI deposition (% of loaded dose) | FPF (% of loaded dose) |
|---|---|---|---|---|
20 | 20 | 13.28 ± 2.08 | 24.05 ± 0.17 | 23.04 ± 0.21 |
30 | 19.09 ± 0.59 | 26.51 ± 0.90 | 25.64 ± 0.91 | |
40 | 14.59 ± 1.30 | 24.14 ± 1.02 | 23.68 ± 0.99 | |
25 | 25 | 17.40 ± 0.78 | 27.76 ± 1.08 | 27.45 ± 0.99 |
40 | 18.76 ± 1.91 | 32.32 ± 0.47 | 32.15 ± 0.47 | |
30 | 30 | 15.06 ± 0.74 | 21.72 ± 0.74 | 21.03 ± 0.85 |
40 | 20.11 ± 2.14 | 27.16 ± 0.79 | 26.60 ± 0.71 |